Vyome Holdings Inc (HIND) Stock Price, Quote & News

Company Profile

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Industry: Biotechnology

Sector: Healthcare

Phone: 973-832-8147

Website: www.vyometx.com

Address:

Harvard Square, One Mifflin Place Suite 400, Cambridge, United States

Mo7ammad920 Oct. 4 at 11:38 PM

$HIND has approximately $7 million cash, providing a runway into 2027, and the company has debt free balance sheet. Recently, they received a buy rating with a price target of $15. Keep holding your shares and forget about $RSLS.

0 · Reply

Vikingsstrade Oct. 3 at 7:41 PM

Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $STI $ALZN $XHG $HIND

0 · Reply

Vikingsstrade Oct. 3 at 5:48 PM

0 · Reply

VyomeInc1 Oct. 3 at 3:36 PM

$HIND The XBI biotech index has bounced off April lows, signaling renewed investor confidence in biotech. Momentum is being fueled by M&A, leaner strategies, and smarter milestone-driven trial designs. EY’s 2025 Biotech Beyond Borders report highlights that capital efficiency is now a core driver of value. Pharmaphorum adds: “The outlook for drug development to treat rare diseases looks encouraging, offering a glimmer of hope to the ~400M people globally who live with these conditions.” At @VyomeInc $HIND we are developing therapies for potential orphan indications where no FDA-approved treatments exist today in some cases — areas that not only address devastating unmet needs but also represent significant addressable market opportunities, potentially in the multiple billions of dollars. Sources: EY 👉 http://ey.com | Pharmaphorum 👉 http://pharmaphorum.com #BiotechRecovery #RareDiseases #XBI #RetailInvesting

0 · Reply

MoonCowBoy Oct. 3 at 12:53 AM

$ALZN $XHG $HIND $GDHG

0 · Reply

Shane393 Oct. 2 at 7:51 PM

$HIND "Clean Cap"

0 · Reply

1Spartantrade1 Oct. 2 at 6:43 PM

Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $XHG $HIND $GDHG $YCBD 🔥

0 · Reply

1Spartantrade1 Oct. 2 at 6:23 PM

0 · Reply

Shane393 Oct. 2 at 5:54 PM

$HIND $4's on deck Short upper 5.60s! Value Cap. Clean Cap, Not toxic at all.

0 · Reply

VyomeInc1 Oct. 2 at 4:24 PM

$HIND Since August 15 listing, we’re rolling with a clean capital structure — no debt, no warrants, no preferred shares, no toxic instruments. All the financing or stock moves before Aug 14 totally belong to old Reshape ($RSLS)—they have nothing to do with our board or leadership. We’re all-in on being dilution-conscious. Insiders, board & officers are locked up. Our playbook = discipline + milestone delivery + alignment with you, the shareholder. Why does this matter? We believe a “clean cap table” helps reduce overhang, align incentives, and build confidence. Let’s build long-term value together. #HIND #CleanCap #ShareholderAlignment #ValueCreation #DisciplinedExecution

0 · Reply